These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 7628525)
1. High lipoprotein(a) levels with predominance of high molecular weight apo(a) isoforms in patients with pulmonary embolism. Császár A; Karádi I; Juhász E; Romics L Eur J Clin Invest; 1995 May; 25(5):368-70. PubMed ID: 7628525 [TBL] [Abstract][Full Text] [Related]
2. Lipoprotein (a) levels and apolipoprotein (a) isoform size in patients with subclinical hypothyroidism: effect of treatment with levothyroxine. Milionis HJ; Efstathiadou Z; Tselepis AD; Bairaktari ET; Tsironis LD; Tsatsoulis A; Elisaf MS Thyroid; 2003 Apr; 13(4):365-9. PubMed ID: 12804105 [TBL] [Abstract][Full Text] [Related]
3. Associations among serum lipoprotein(a) levels, apolipoprotein(a) phenotypes, and myocardial infarction in patients with extremely low and high levels of serum lipoprotein(a). Saku K; Zhang B; Liu R; Shirai K; Arakawa K Jpn Circ J; 1999 Sep; 63(9):659-65. PubMed ID: 10496479 [TBL] [Abstract][Full Text] [Related]
5. Lipoprotein(a) levels and apolipoprotein(a) isoforms related to life style risk factors. Ishikawa S; Deguchi T; Hara K; Takuma S; Kayaba K; Tsutsumi A; Kario K; Igarashi M J Epidemiol; 1999 Feb; 9(1):32-9. PubMed ID: 10098351 [TBL] [Abstract][Full Text] [Related]
6. Lipoprotein(a) serum concentrations and apolipoprotein(a) phenotypes in mild and moderate renal failure. Kronenberg F; Kuen E; Ritz E; Junker R; König P; Kraatz G; Lhotta K; Mann JFE; Müller GA; Neyer U; Riegel W; Riegler P; Schwenger V; VON Eckardstein A J Am Soc Nephrol; 2000 Jan; 11(1):105-115. PubMed ID: 10616846 [TBL] [Abstract][Full Text] [Related]
7. Serum lipids, lipoprotein(a) and apo(a) isoforms in patients with established coronary artery disease and their relation to disease and prognosis after coronary by-pass surgery. Lindén T; Taddei-Peters W; Wilhelmsen L; Herlitz J; Karlsson T; Ullström C; Wiklund O Atherosclerosis; 1998 Mar; 137(1):175-86. PubMed ID: 9568750 [TBL] [Abstract][Full Text] [Related]
9. Predictors of plasma lipoprotein(a) concentration in the West of Scotland Coronary Prevention Study cohort. Gaw A; Docherty G; Brown EA; Ford I Atherosclerosis; 1999 Apr; 143(2):445-50. PubMed ID: 10217375 [TBL] [Abstract][Full Text] [Related]
10. [Association of lipoprotein(a) and apolipoprotein(a) phenotypes with coronary and carotid atherosclerosis in CHD men]. Ezhov MV; Afanas'eva OI; Benevolenskaia GF; Savchenko AP; Balakhonova TV; Liakishev AA; Pokrovskiĭ SN Ter Arkh; 2000; 72(1):28-32. PubMed ID: 10687202 [TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein(a) phenotypes and lipoprotein(a) concentrations in patients with renal failure. Milionis HJ; Elisaf MS; Tselepis A; Bairaktari E; Karabina SA; Siamopoulos KC Am J Kidney Dis; 1999 Jun; 33(6):1100-6. PubMed ID: 10352198 [TBL] [Abstract][Full Text] [Related]
12. Decrease of Lp(a) during weight reduction in obese children is modified by the apo(a) kringle-IV copy number variation. Brandstätter A; Lingenhel A; Zwiauer K; Strobl W; Kronenberg F Int J Obes (Lond); 2009 Oct; 33(10):1136-42. PubMed ID: 19636317 [TBL] [Abstract][Full Text] [Related]